000			02000 a2200589 4500
005			20250516070132.0
264		0	_c20111220
008			201112s 0 0 eng d
022			_a1533-4406
024	7		_a10.1056/NEJMoa1104875 _2doi
040			_aNLM _beng _cNLM
100	1		_aSterling, Timothy R
245	0	0	_aThree months of rifapentine and isoniazid for latent tuberculosis infection. _h[electronic resource]
260			_bThe New England journal of medicine _cDec 2011
300			_a2155-66 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAntitubercular Agents _xadministration & dosage
650	0	4	_aDirectly Observed Therapy
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aIntention to Treat Analysis
650	0	4	_aIsoniazid _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProspective Studies
650	0	4	_aRifampin _xadministration & dosage
650	0	4	_aRisk Factors
650	0	4	_aSelf Administration
650	0	4	_aTuberculosis _xdrug therapy
650	0	4	_aVirus Latency
700	1		_aVillarino, M Elsa
700	1		_aBorisov, Andrey S
700	1		_aShang, Nong
700	1		_aGordin, Fred
700	1		_aBliven-Sizemore, Erin
700	1		_aHackman, Judith
700	1		_aHamilton, Carol Dukes
700	1		_aMenzies, Dick
700	1		_aKerrigan, Amy
700	1		_aWeis, Stephen E
700	1		_aWeiner, Marc
700	1		_aWing, Diane
700	1		_aConde, Marcus B
700	1		_aBozeman, Lorna
700	1		_aHorsburgh, C Robert
700	1		_aChaisson, Richard E
773	0		_tThe New England journal of medicine _gvol. 365 _gno. 23 _gp. 2155-66
856	4	0	_uhttps://doi.org/10.1056/NEJMoa1104875 _zAvailable from publisher's website
999			_c21373504 _d21373504